Charles River Laboratories International, Inc. (CRL) vs Henry Schein, Inc. (HSIC)
HSIC leads on 8 of 13 compared metrics.
A side-by-side comparison of Charles River Laboratories International, Inc. and Henry Schein, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 23, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
CRL
Charles River Laboratories International, Inc.
$181.56Healthcare
HSIC
Henry Schein, Inc.
$78.67Healthcare
Total return — CRL vs HSIC
growth of $100 · last 26yCRL +725.3%HSIC +2277.6%HSIC compounded faster
CRL HSIC
CRL vs HSIC: by the numbers
- •HSIC is the larger company ($8.96B vs $8.75B market cap).
- •HSIC is profitable (2.95% net margin) while CRL runs a net loss (-4.59%).
- •CRL grew revenue faster over the past five years (5.77% vs 4.74% CAGR).
Which is better, CRL or HSIC?
Metric tally: CRL 5 · HSIC 8It depends on what you're optimizing for:
GrowthCRL(faster 5Y revenue CAGR)
QualityCRL(higher ROIC)
Metrics side by side
Valuation
| Metric | CRL | HSIC |
|---|---|---|
| P/E ratio | — | 23.77 |
| Forward P/E | 14.73 | 14.71 |
| P/S ratio | 2.21 | 0.68● |
| P/B ratio | 3.02 | 2.80● |
| PEG ratio | — | 3.23 |
| EV / EBITDA | 40.45 | 12.72● |
| FCF yield | 4.40% | 4.72%● |
Profitability
| Metric | CRL | HSIC |
|---|---|---|
| Gross margin | 31.86%● | 29.69% |
| Operating margin | 11.77%● | 5.60% |
| Net margin | -4.59% | 2.95%● |
| ROE | -6.28% | 12.09%● |
| ROIC | 8.36%● | 6.58% |
Growth (annualized)
| Metric | CRL | HSIC |
|---|---|---|
| Revenue CAGR (5Y) | 5.77%● | 4.74% |
| EPS CAGR (5Y) | -40.99% | -0.74%● |
| FCF CAGR (5Y) | -3.98%● | -4.53% |
| Total return CAGR (5Y) | -12.99% | 0.58%● |
Frequently asked
- Which is better, CRL or HSIC?
- It depends on your goal. growth: CRL (faster 5Y revenue CAGR); quality: CRL (higher ROIC). Across all compared metrics, HSIC leads 8 to 5.
- Which has grown faster, CRL or HSIC?
- Over the past five years, CRL grew revenue faster — CRL at a 5.77% CAGR versus HSIC at 4.74%.
- Is CRL or HSIC more profitable?
- HSIC runs the higher net margin — CRL at -4.59% versus HSIC at 2.95%.
- Which has been the better investment, CRL or HSIC?
- Over the past 10-year, CRL delivered the higher annualized total return — CRL at 8.10% versus HSIC at 1.38%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Charles River Laboratories International P/E ratioHenry Schein P/E ratioCharles River Laboratories International dividend yieldHenry Schein dividend yieldCharles River Laboratories International ROEHenry Schein ROECharles River Laboratories International operating marginHenry Schein operating marginCharles River Laboratories International revenue growthHenry Schein revenue growthCharles River Laboratories International free cash flowHenry Schein free cash flow
Charles River Laboratories International & Henry Schein appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 23, 2026.